Bozepinib: A Promising Selective Derivative Targeting Breast Cancer Stem Cells
Bozepinib is a potent antitumour compound that shows an IC50 of 0.166 μM against MDA-MB-231 human breast cancer cell line. It is also a very selective drug that presents a therapeutic index (TI) of 11.0 against MDA-MB-231 in relation to the normal MCF-10A. It is important to identify new cancer stem...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/71273 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Bozepinib: A Promising Selective Derivative Targeting Breast Cancer Stem Cells
- Isolation of Breast Cancer Stem Cells by Single-Cell Sorting
- Therapeutic Approaches Targeting Cancer Stem Cells
- Breast Cancer Stem Cells
- Breast Cancer Stem Cells
- Apoptosis as a Therapeutic Target in Cancer and Cancer Stem Cells: Novel Strategies and Futures Perspectives
- The Role of HSP70 in Regulation of Breast Cancer Stem Cells and Apoptotic Pathway